Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease.
Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factors.
Pulmonary toxicity of bischloronitrosourea: report of a case with transient response to corticosteroid therapy.
Multiple pulmonary lesions in a patient treated with BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) for glioblastoma multiforme.
